60 studies found for:    Open Studies | "Niacin"
Show Display Options
Rank Status Study
21 Recruiting The Topical Niacin Skin Flush Test in First Episode Psychosis
Conditions: Psychotic Disorders;   Schizophrenia
Intervention: Other: skin test
22 Recruiting Gulf War Illness: Evaluation of an Innovative Detoxification Program
Condition: Persian Gulf War Syndrome in Veteran
Intervention: Other: Hubbard detoxification program
23 Unknown  Assessing the Effects of a Topically Applied Cream to Clitoral Blood Flow
Condition: Female Sexual Dysfunction
Interventions: Drug: arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%;   Drug: Topical study cream;   Drug: GRAS cream
24 Recruiting Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Quercetin
25 Not yet recruiting Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation
Condition: Diarrhea
Interventions: Dietary Supplement: MNP;   Dietary Supplement: preventive zinc supplement;   Dietary Supplement: therapeutic zinc supplement;   Dietary Supplement: preventive placebo supplement;   Dietary Supplement: therapeutic placebo supplement;   Dietary Supplement: placebo powder
26 Recruiting Feasibility and Effectiveness of Micronutrients as Palliative Care Therapy in Patients With Congestive Heart Failure
Conditions: Congestive Heart Failure;   Ischemic Cardiomyopathy
Intervention: Drug: Micronutrients
27 Unknown  A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)
Condition: Schizophrenia
Intervention:
28 Recruiting A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Condition: Cardiovascular Diseases
Interventions: Drug: AMR101;   Drug: Placebo
29 Unknown  Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex
Conditions: Lack of Appetite;   Anorexia
Interventions: Drug: Apevinat BC;   Drug: Vitamin Complex
30 Recruiting Iron and Prebiotics Fortification in Kenyan Infants
Conditions: Anemia;   Iron Deficiency;   Diarrhea;   Malaria;   Respiratory Tract Infections (RTI)
Intervention: Dietary Supplement: Fortified maize porridge
31 Unknown  Prostate Cancer Prevention Trial With Quercetin and Genistein
Condition: Primary Prevention of Prostate Cancer
Interventions: Dietary Supplement: Quercetin supplement;   Dietary Supplement: Genistein supplement;   Dietary Supplement: Placebo
32 Unknown  Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases
Conditions: Preeclampsia;   Pregnancy;   Micronutrients;   Exercise
Interventions: Behavioral: Regular aerobic physical exercise;   Dietary Supplement: Micronutrients;   Other: Activities of daily living + placebo
33 Recruiting Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Hepatocellular Carcinoma;   Advanced Adult Hepatocellular Carcinoma;   BCLC Stage C Adult Hepatocellular Carcinoma;   BCLC Stage D Adult Hepatocellular Carcinoma;   Localized Non-Resectable Adult Liver Carcinoma;   Recurrent Adult Liver Carcinoma
Interventions: Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Sorafenib Tosylate
34 Recruiting Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer
Conditions: Recurrent Renal Cell Carcinoma;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis;   Drug: Pazopanib Hydrochloride;   Other: Pharmacological Study;   Drug: Sorafenib Tosylate;   Drug: Sunitinib Malate;   Biological: Trebananib
35 Recruiting Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adult Hepatocellular Carcinoma;   Adult Solid Neoplasm;   Advanced Adult Hepatocellular Carcinoma;   Localized Non-Resectable Adult Liver Carcinoma;   Recurrent Adult Liver Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Navitoclax;   Other: Pharmacological Study;   Drug: Sorafenib Tosylate
36 Recruiting Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia
Condition: Adult Acute Myeloid Leukemia in Remission
Interventions: Procedure: Bone Marrow Transplantation;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Sorafenib Tosylate
37 Recruiting Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases
Condition: Tumors Metastatic to Brain
Interventions: Drug: sorafenib tosylate;   Radiation: stereotactic radiosurgery;   Other: laboratory biomarker analysis
38 Recruiting Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: placebo;   Other: laboratory biomarker analysis
39 Recruiting Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma
Conditions: Adult Solid Neoplasm;   Recurrent Melanoma;   Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Drug: Riluzole;   Drug: Sorafenib Tosylate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
40 Unknown  Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Condition: Liver Cancer
Interventions: Drug: doxorubicin-eluting beads;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Other: pharmacological study;   Procedure: quality-of-life assessment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years